RFID Costs Pose Hurdle For OTC Industry, Pfizer Exec Says
This article was originally published in The Rose Sheet
Executive Summary
The high cost of Radio Frequency Identification technology may preclude its expanded use in the OTC arena even as firms are exploring the technology for use with Rx drugs, according to Tim Marsh, technical manager of global packaging technology for Lubriderm marketer Pfizer